Pediatrix Medical Group, Inc.

Name: Pediatrix Medical Group, Inc. standardized financial statements, quarterly
Creator: Listed

MDNYSECIK 893949HealthcareFiscal year ends Dec 31

Share this page

Link

Story card, 1080 × 1920

Standardized line items from XBRL company facts, the last twelve quarters. Negative values are in parentheses. A figure marked d is derived from year-to-date figures.

Income statement

Revenue$501.4m, Q3 FY2026

Operating income$65.2m, Q3 FY2026

Net income$47.0m, Q3 FY2026

Pediatrix Medical Group, Inc., income statement, quarterly
Line item	Unit	Q4 FY20232023-12-31	Q1 FY20242024-03-31	Q2 FY20242024-06-30	Q3 FY20242024-09-30	Q4 FY20242024-12-31	Q1 FY20252025-03-31	Q2 FY20252025-06-30	Q3 FY20252025-09-30	Q4 FY20252025-12-31	Q1 FY20262026-03-31	Q2 FY20262026-06-30	Q3 FY20262026-09-30
Revenue	$m	496	495	504	511	502	458	469	493	494	476	488	501
Operating income	$m	(111)	15.9	(158)	33.8	39.3	32.1	59.9	68.1	48.8	41.7	56.9	65.2
Interest expense	$m	10.1	10.6	10.3	10.1	9.7	9.2	9.1	8.9	8.7	8.3	8.2	8.1
Income tax	$m	(14.6)	3.8	(14.7)	5.8	2.8	7.4	15.7	16.1	11.9	9.3	14.2	18.0
Net income	$m	(124)	4.0	(153)	19.4	30.5	20.7	39.3	71.7	33.7	29.6	39.8	47.0
Diluted EPS	$ per share	not reported	0.05	(1.84)	0.23	not reported	0.24	0.46	0.84	not reported	0.36	0.49	0.59
Basic EPS	$ per share	not reported	0.05	(1.84)	0.23	not reported	0.25	0.46	0.85	not reported	0.37	0.50	0.61

Balance sheet

Cash and equivalents$311.9m, Q3 FY2026

Long-term debt$611.2m, FY2024

Shareholders' equity$849.6m, Q3 FY2026

Pediatrix Medical Group, Inc., balance sheet, quarterly
Line item	Unit	FY20232023-12-31	Q1 FY20242024-03-31	Q2 FY20242024-06-30	Q3 FY20242024-09-30	FY20242024-12-31	Q1 FY20252025-03-31	Q2 FY20252025-06-30	Q3 FY20252025-09-30	FY20252025-12-31	Q1 FY20262026-03-31	Q2 FY20262026-06-30	Q3 FY20262026-09-30
Cash and equivalents	$m	73.3	8.0	19.4	104	230	99.0	225	340	375	206	289	312
Current assets	$m	483	427	429	528	640	492	613	717	764	587	660	684
Total assets	$m	2,220	2,168	1,995	2,077	2,153	1,993	2,102	2,199	2,247	2,070	2,130	2,139
Current liabilities	$m	389	247	310	373	434	271	341	393	459	443	502	536
Total liabilities	$m	1,371	1,312	1,289	1,344	1,388	1,204	1,268	1,309	1,381	1,192	1,249	1,290
Long-term debt	$m	622	not reported	not reported	not reported	611	not reported	not reported	not reported	not reported	not reported	not reported	not reported
Current portion of debt	$m	not reported	not reported	not reported	not reported	not reported	not reported	not reported	not reported	not reported	not reported	not reported	not reported
Shareholders' equity	$m	849	856	706	732	765	789	834	891	866	879	881	850

Cash flow

Operating cash flow$117.3m, Q3 FY2026

Share repurchases$83.0m, Q3 FY2026

Pediatrix Medical Group, Inc., cash flow, quarterly
Line item	Unit	Q4 FY20232023-12-31	Q1 FY20242024-03-31	Q2 FY20242024-06-30	Q3 FY20242024-09-30	Q4 FY20242024-12-31	Q1 FY20252025-03-31	Q2 FY20252025-06-30	Q3 FY20252025-09-30	Q4 FY20252025-12-31	Q1 FY20262026-03-31	Q2 FY20262026-06-30	Q3 FY20262026-09-30
Operating cash flow	$m	69.3	(125)	107	91.8	133	(117)	137	137	114	(130)	125	117
Share repurchases	$m	0.0	0.9	0.0	0.2	0.6	1.6	0.2	20.9	64.0	21.5	42.7	83.0

Diluted shares (weighted)79.73m, Q3 FY2026

Pediatrix Medical Group, Inc., shares, quarterly
Line item	Unit	Q1 FY20232023-03-31	Q2 FY20232023-06-30	Q3 FY20232023-09-30	Q1 FY20242024-03-31	Q2 FY20242024-06-30	Q3 FY20242024-09-30	Q1 FY20252025-03-31	Q2 FY20252025-06-30	Q3 FY20252025-09-30	Q1 FY20262026-03-31	Q2 FY20262026-06-30	Q3 FY20262026-09-30
Diluted shares (weighted)	m shares	82.3	82.7	83.0	83.3	83.3	84.5	85.4	85.5	85.6	83.1	81.4	79.7

Shares outstanding: 78.12m at Oct 27, 2026, from the cover of the 10-Q filed Oct 29, 2026.

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 29, 2026, 07:14 ET. Listed shows no prices and gives no investment advice.